glp-1compoundpharmacy

The formulation archive
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.

Pharmacy-Direct vs Telehealth-Bundled Compounding: Which Path Costs Less in 2026

Price verification — October 26, 2026

This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.

  • Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
  • Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
  • Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
  • Sesame annual-commitment terms: Official source.

These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due. Compounded GLP-1 products are not FDA-approved. Their availability, lawful compounding circumstances and product claims require separate verification. FDA policy.

The two dominant models for accessing compounded GLP-1s work very differently on price, service, and continuity. Pharmacy-direct services are typically leaner and cheaper. Telehealth-bundled services are typically more expensive but include the prescriber, the fulfillment, and the coaching in one login. Here's how to pick.

The Two Models

In the pharmacy-direct model, you get a prescription from an independent prescriber (your PCP, a hormone specialist, or a standalone telehealth service that only writes prescriptions), then send that prescription to a compounding pharmacy that fulfills it. The pharmacy has no bundled care team — its job is compounding and shipping.

In the telehealth-bundled model, one company owns the entire experience: intake, prescription, fulfillment (typically through a partner or in-house pharmacy), care team, and app. You pay one subscription that covers everything.

Cost Comparison

Pharmacy-direct is typically cheaper on paper. You might pay $75–$150 for the initial prescriber consult (one-time), $30–$50 for follow-ups every 3–6 months, and $150–$250 for a monthly compounded vial from an independent pharmacy. That runs $180–$300/month steady-state after the initial consult.

Telehealth-bundled tends to run $250–$400/month depending on the platform and dose tier, but includes all consults, all follow-ups, care team access, and often coaching/education. No separate prescriber bills, no separate pharmacy invoices.

Embody

Injectable semaglutide — pricing varies

Injectable semaglutide only; a lead compounded-injectable option.

  • Injectable semaglutide focus
  • Standard 12-week titration
  • Direct-to-patient pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →
Sponsored partner · Weight-management telehealthGala GLP-1

Review program enrollment, whether medication is compounded, dispensing pharmacy information, and the total ongoing price.

Explore Gala GLP-1 ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Where Pharmacy-Direct Wins

Pharmacy-direct wins if you: already have a PCP or established prescriber comfortable prescribing GLP-1s; know your dose and titration plan and don't need heavy check-in cadence; have a pharmacy relationship you trust; want to minimize monthly spend; or want to keep your compounded product source separate from your intake platform.

SPONSORED CARE OPTION

Sesame

Compare licensed-clinician services and ask about pharmacy sourcing, FDA-approved treatment options and itemized charges. Compounded medicines are not FDA-approved.

Pricing, medication access, service area and plan terms must be confirmed with the provider. This is not a drug-specific checkout link.

Explore Sesame program ↗
Sponsored partner · Weight-management telehealthOak GLP-1

Review current treatment pathways, screening and follow-up, and clarify which medication and monthly charges apply.

Explore Oak GLP-1 ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Where Bundled Wins

Bundled wins if you: don't have an established prescriber and don't want to build one; value a single app and single support channel; want a care team available for questions during titration; want the pharmacy relationship managed for you if the pharmacy changes; or are early in treatment and would benefit from the coaching layer.

Sponsored partner · Compounded and branded pathwaysGobyMeds

Explore the program’s treatment pathways and ask which medication type, pharmacy, enrollment requirements and recurring charges apply to your location.

Explore GobyMeds ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.
Sponsored partner · Compounded semaglutide listingHealthRX — semaglutide

Explore HealthRX’s compounded semaglutide listing. Compounded medications are not FDA-approved; verify the current legal pathway, pharmacy and total price.

Explore HealthRX — semaglutide ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

The Hybrid Path

Some patients start bundled to learn the ropes, then move pharmacy-direct once they're steady-state. Others start pharmacy-direct and add a bundled service only if they hit a titration issue or want coaching. Both paths are legitimate. The point is to be intentional about which model fits your current stage, not to default to the one your first-search-result recommends.

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder offering compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range per dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

SHED

Starts lower, $399/mo at 7.5mg+

Note: SHED's price jumps to $399/mo once you titrate to 7.5mg or higher.

  • Lower entry pricing
  • Price jump at 7.5mg+
  • Compounded semaglutide + tirzepatide
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

Where to Start

Embody

Injectable semaglutide — pricing varies

Injectable semaglutide only; a lead compounded-injectable option.

  • Injectable semaglutide focus
  • Standard 12-week titration
  • Direct-to-patient pharmacy shipping
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder offering compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range per dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →

SHED

Starts lower, $399/mo at 7.5mg+

Note: SHED's price jumps to $399/mo once you titrate to 7.5mg or higher.

  • Lower entry pricing
  • Price jump at 7.5mg+
  • Compounded semaglutide + tirzepatide
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Compare current GLP-1 options →